Family-Specific Variants and the Limits of Human Genetics.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Trends in Molecular Medicine

• Publication date

  2016-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molmed.2016.09.007PMID 27742414PMCID PMC6197474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program

  2017cited by this paper
• Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.

  2016cited by this paper
• The Double Helix: Applying an Ethic of Care to the Duty to Warn Genetic Relatives of Genetic Information.

  2016cited by this paper
• Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

  2016influential reference
• Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India

  2016cited by this paper
• Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.

  2016cited by this paper
• Detection of Germline Mutation in Hereditary Breast and/or Ovarian Cancers by Next-Generation Sequencing on a Four-Gene Panel.

  2016cited by this paper
• CADD score has limited clinical validity for the identification of pathogenic variants in non-coding regions in a hereditary cancer panel

  2016cited by this paper
• Improving performance of multigene panels for genomic analysis of cancer predisposition

  2016cited by this paper
• Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.

  2016influential reference
• Practical considerations in the clinical application of whole‐exome sequencing

  2016cited by this paper
• Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.

  2016cited by this paper
• RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance.

  2016cited by this paper
• Family Studies for Classification of Variants of Uncertain Classification: Current Laboratory Clinical Practice and a New Web-Based Educational Tool

  2016cited by this paper
• Aligning Policy to Promote Cascade Genetic Screening for Prevention and Early Diagnosis of Heritable Diseases

  2015cited by this paper
• Massively Parallel Functional Analysis of BRCA1 RING Domain Variants

  2015cited by this paper
• Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel

  2015cited by this paper
• Use of panel tests in place of single gene tests in the cancer genetics clinic

  2015cited by this paper
• The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities.

  2015cited by this paper
• Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.

  2015cited by this paper
• Widespread macromolecular interaction perturbations in human genetic disorders.

  2015cited by this paper
• Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis.

  2015cited by this paper
• Exome sequencing results in successful riboflavin treatment of a rapidly progressive neurological condition

  2015cited by this paper
• Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing

  2015cited by this paper
• Analysis of protein-coding genetic variation in 60,706 humans

  2015cited by this paper
• KBG Syndrome: A Case Report and Longitudinal Assessment of Long‐Acting Recombinant Human Growth Hormone Therapy

  2015influential reference
• Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics

  2015cited by this paper
• Massively parallel enzyme kinetics reveals the substrate recognition landscape of the metalloprotease ADAMTS13

  2015cited by this paper
• Comparison of locus-specific databases for BRCA1 and BRCA2 variants reveals disparity in variant classification within and among databases

  2015cited by this paper
• Lynch Syndrome Associated with Two MLH1 Promoter Variants and Allelic Imbalance of MLH1 Expression

  2015cited by this paper
• A global reference for human genetic variation

  2015cited by this paper
• High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities.

  2015cited by this paper
• Leveraging distant relatedness to quantify human mutation and gene conversion rates

  2015influential reference
• A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.

  2015cited by this paper
• Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings

  2015cited by this paper
• Molecular findings among patients referred for clinical whole-exome sequencing.

  2014cited by this paper
• Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.

  2014cited by this paper
• Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients

  2014cited by this paper
• The Validation and Clinical Implementation of BRCAplus: A Comprehensive High-Risk Breast Cancer Diagnostic Assay

  2014cited by this paper
• Characteristics of neutral and deleterious protein-coding variation among individuals and populations.

  2014cited by this paper
• Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2 negative patients with early onset breast cancer

  2014cited by this paper
• Clinical interpretation and implications of whole-genome sequencing.

  2014cited by this paper
• Deep sequencing with intronic capture enables identification of an APC exon 10 inversion in a patient with polyposis

  2014cited by this paper
• Mutations in NGLY1 cause an inherited disorder of the endoplasmic reticulum–associated degradation pathway

  2014cited by this paper
• Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes

  2013cited by this paper
• Assessing the Impact of Population Stratification on Association Studies of Rare Variation

  2013cited by this paper
• APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis.

  2013influential reference
• Marbled Inflation From Population Structure in Gene‐Based Association Studies With Rare Variants

  2013cited by this paper
• BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.

  2013cited by this paper
• Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress

  2013influential reference
• Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling.

  2013influential reference
• A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization

  2013cited by this paper
• Towards precision medicine: advances in computational approaches for the analysis of human variants.

  2013cited by this paper
• A mosaic PTEN mutation causing Cowden syndrome identified by deep sequencing

  2013cited by this paper
• De novo mutations in human genetic disease

  2012cited by this paper
• Essential Elements of Genetic Cancer Risk Assessment, Counseling, and Testing: Updated Recommendations of the National Society of Genetic Counselors

  2012cited by this paper
• Varieties of Uncertainty in Health Care

  2011cited by this paper
• Varieties of uncertainty in health care: a conceptual taxonomy.

  2011cited by this paper
• Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility.

  2011influential reference
• Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: Variant reclassification and surgical decisions

  2011cited by this paper
• Developing a National Registry for conditions identifiable through newborn screening

  2009cited by this paper
• Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results

  2008cited by this paper
• A full-likelihood method for the evaluation of causality of sequence variants from family data.

  2003cited by this paper
• Clinical Interpretation and Recommendations for Patients with a Variant of Uncertain Significance in BRCA1 or BRCA2: A Survey of Genetic Counseling Practice

  2002influential reference
• Cardiovascular physiology in the twentieth century: great strides and missed opportunities.

  1998cited by this paper
• T E C H N I C a L a D V a N C E Open Access

  year unknowncited by this paper
• Bmc Cancer

  year unknowncited by this paper

• Characterizing trends in clinical genetic testing: A single-center analysis of EHR data from 1.8 million patients over two decades

  2025cites this paper
• Systematic and proactive evaluation of AIRE missense variant effects

  2025cites this paper
• Mendelian causes of early-onset emphysema: a review of the current literature

  2025cites this paper
• The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR.

  2025cites this paper
• Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicine

  2025cites this paper
• Comprehensively Testing the Function of Missense Variation in the STK11 Tumour Suppressor

  2025cites this paper
• Functional residuomics - analyzing how missense mutations impact cellular systems.

  2025cites this paper
• Framework for standardized genetic testing recommendations for chronic kidney disease in Ontario

  2025cites this paper
• Site-saturation mutagenesis of 500 human protein domains

  2024cites this paper
• Expansion of clinical genetic testing since the completion of the human genome project

  2024cites this paper
• A content analysis of parents’ reflections on pathogenic and uncertain pediatric oncology germline sequencing results

  2024cites this paper
• Multiplexed Functional Assessments of MYH7 Variants in Human Cardiomyocytes

  2024cites this paper
• Protein domains provide a new layer of information for classifying human variations in rare diseases

  2023influential citation
• Deep generative modeling of the human proteome reveals over a hundred novel genes involved in rare genetic disorders

  2023cites this paper
• Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey

  2023cites this paper
• How human genetic context can inform pathogenicity classification: FGFR1 variation in idiopathic hypogonadotropic hypogonadism

  2023cites this paper
• Multiplexed functional assessments of MYH7 variants in human cardiomyocytes at scale

  2023cites this paper
• An Atlas of Variant Effects to understand the genome at nucleotide resolution

  2023cites this paper
• Predictors of the utility of clinical exome sequencing as a first-tier genetic test in patients with Mendelian phenotypes: results from a referral center study on 603 consecutive cases

  2023cites this paper
• The Challenge of Genetic Variants of Uncertain Clinical Significance

  2022influential citation
• Genetics of Inherited thrombocytopenias.

  2022cites this paper
• Comparative Analyses of Turkish Variome and Widely Used Genomic Variation Databases for the Evaluation of Rare Sequence Variants in Turkish Individuals: Idiopathic Hypogonadotropic Hypogonadism as a Disease Model

  2022cites this paper
• Utility and Diversity: Challenges for Genomic Medicine.

  2021cites this paper
• From variant to function in human disease genetics

  2021cites this paper
• Amyotrophic Lateral Sclerosis Genetic Access Program

  2021cites this paper
• A SIMPLE AND FLEXIBLE TEST OF SAMPLE EXCHANGEABILITY WITH APPLICATIONS TO STATISTICAL GENOMICS.

  2021cites this paper
• Modeling the impact of data sharing on variant classification

  2021cites this paper
• How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline predisposition to myeloid malignancies

  2020cites this paper
• Family-specific genetic variants: Principles, detection, and clinical interpretation

  2020cites this paper
• Variant of Uncertain Significance-Related Uncertainty in Breast Cancer Genomics

  2020cites this paper
• Incorporating user feedback in the design of a genetics analysis tool: A two-part approach

  2019cites this paper
• Exploring the effect of ascertainment bias on genetic studies that use clinical pedigrees

  2019cites this paper
• Technical, Biological, and Systems Barriers for Molecular Clinical Decision Support.

  2019cites this paper
• The effects of genomic germline variant reclassification on clinical cancer care

  2019cites this paper
• Understanding Context of Use and Perceptions of Usability of Cosegregation Analysis Tool AnalyzeMyVariant

  2018cites this paper
• Patient goals, motivations, and attitudes in a patient‐driven variant reclassification study

  2018cites this paper
• Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance

  2018cites this paper
• Making Sense of the Genome Remains a Work in Progress.

  2018cites this paper
• Experiences of patients seeking to participate in variant of uncertain significance reclassification research

  2018cites this paper
• Multiplex Assessment of Protein Variant Abundance by Massively Parallel Sequencing

  2018cites this paper
• Clinical judgement in precision medicine.

  2018cites this paper
• Pharmacogenomics of CYP2C9: Functional and Clinical Considerations†

  2017cites this paper
• Identification of novel risk variants for sarcoma and other cancers by whole exome sequencing analysis in cancer cluster families

  2017cites this paper
• To realize the goals of precision medicine , the hierarchy of evidence pyramidmust yield to amore horizontal conception ofmedical knowledge

  2017cites this paper
• Knowledge for Precision Medicine: Mechanistic Reasoning and Methodological Pluralism.

  2017cites this paper
• Impact of germline panel size on hereditary cancer: findings of variants of uncertain significance in the Brazilian public health population selected for high hereditary cancer risk

  year unknowncites this paper